CIM — Chimera Investment Income Statement
0.000.00%
Last trade - 00:00- $1.05bn
- $10.93bn
- $741.67m
- 53
- 91
- 25
- 57
Annual income statement for Chimera Investment, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,381 | 1,197 | 983 | 697 | 742 |
| Cost of Revenue | |||||
| Gross Profit | 586 | 644 | 620 | 327 | 200 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 968 | 1,108 | 308 | 1,210 | 615 |
| Operating Profit | 414 | 89 | 675 | -513 | 126 |
| Net Income Before Taxes | 414 | 89 | 675 | -513 | 126 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 414 | 88.9 | 670 | -513 | 126 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 414 | 88.9 | 670 | -513 | 126 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 341 | 15.1 | 599 | -587 | 52.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.79 | 0.307 | 3.59 | -2.5 | 0.208 |
| Dividends per Share |